fbpx

GBM Awareness Day is July 17. Join us in raising awareness all month long! Learn more.

MindMatters White Logo

Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.

Subscribe to MindMatters

All in the Family: Raising Awareness and Support for GBM Research

GBM Awareness Day: July 19, 2023
GBM Awareness Day: July 19, 2023

As we approach the fifth annual Glioblastoma (GBM) Awareness Day on July 19, the American Brain Tumor Association (ABTA) asks you to join us to raise $50,000 for breakthrough GBM research.

Thanks to KM Legacy Foundation, the first $25,000 donated towards GBM Awareness Day will be matched dollar-for-dollar. The KM Legacy foundation was founded by Katie Monson, daughter of Danny Monson, ABTA board member and current treasurer. Katie was only 19 years old when she was diagnosed with glioblastoma (GBM) in 2017. 

She created the KM Legacy Foundation to raise money for brain cancer awareness and research. Though Katie passed away in 2018 from GBM, her family continues to lead the foundation to advance progress in the fight against brain tumors and to honor her memory. 

GBM is the most common, complex, treatment-resistant, and deadliest type of brain cancer. The aggressive nature of GBM, which has only a five-year survival rate of 5% among adults, makes research, access to innovative treatments and reliable information even more important.

Because we understand the daily challenges and financial burdens that come with battling GBM, we want to make sure you know about some of the free programs and services we offer:   

Picture of Jessie Schlacks

Jessie Schlacks

Jessie is Managing Editor of the bi-monthly e-newsletter MindMatters. Submit story ideas or questions to jschlacks@abta.org.


 

Advancing Brain Tumor Research and Support

Thanks to the generous support of donors like you, the American Brain Tumor Association has invested over $35 million in life-changing brain tumor research, helping pave the way for breakthroughs like the FDA approval of vorasidenib, a groundbreaking treatment for low-grade glioma. Through our Meet Hope Head On campaign, we continue funding critical research and providing free resources for patients and caregivers—bringing hope and advancing care for the brain tumor community.

Share This Content:

Share:

More Posts

Upcoming Events

Educational Resources

Always free for patients & caregivers

Gina & Tim Abbas
Caregiver & Anaplastic Astrocytoma Survivor

Double Your Impact for Brain Tumor Families

Donate now and your gift will be matched thanks to the Will Hicks Charitable Association.